Respective roles of non-pharmaceutical interventions in bronchiolitis outbreaks: an interrupted time-series analysis

Lea Lenglart1,2, Naim Ouldali3,4,5,6,2, Kate Honeyford7

  • 1Paediatric Emergency Department, Robert Debré University Hospital, AP-HP, Université de Paris, Paris, France.

Insights

Non-pharmaceutical interventions (NPIs) significantly reduced bronchiolitis outbreaks in children. Full lockdowns, school closures, mask-wearing, and teleworking were key NPIs that lowered the incidence of this common childhood respiratory illness.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Bronchiolitis is a significant cause of illness and death in young children globally.
  • Non-pharmaceutical interventions (NPIs) for COVID-19 may have impacted bronchiolitis outbreaks.
  • Understanding the specific impact of each NPI is crucial for future public health strategies.

Purpose of the Study:

  • To assess the impact of individual NPIs on bronchiolitis outbreaks across 14 European countries.
  • To differentiate the effects of various NPIs on the incidence of pediatric bronchiolitis.
  • To inform public health policies for managing bronchiolitis seasonality.

Main Methods:

  • A quasi-experimental, interrupted time-series analysis was employed.
  • Data from 27 pediatric emergency departments across Europe (January 2018-March 2021) were analyzed.
  • Seasonally adjusted multivariable quasi-Poisson regression modeled the association between NPIs and bronchiolitis trends.

Main Results:

  • A 78% overall reduction in bronchiolitis cases was observed following NPI implementation.
  • Significant reductions were seen in countries with strict measures, ranging from 36% to 97%.
  • Full lockdown, secondary school closure, indoor mask-wearing, and teleworking were independently associated with decreased bronchiolitis incidence.

Conclusions:

  • Multiple NPIs, including lockdowns, school closures, and mask mandates, effectively reduced bronchiolitis outbreaks.
  • These findings suggest that specific NPIs can be considered to mitigate the global burden of bronchiolitis.
  • Public health interventions targeting respiratory virus transmission show promise in controlling pediatric diseases.
Abstract

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
170
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
552
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
277
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
346
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K